(Q27853025)

English

Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

2 references

PubMed publication ID

13 November 2016

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

0 references

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Yao-Kuang Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Chun-Yao Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Mei-Chen Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Chou-Chin Lan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Chih-Hsin Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Kuei-Tien Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

25 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Medical Oncology

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

79

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Prognostic versus predictive value of biomarkers in oncology.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Investigations of survivin: the past, present and future

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Exploring the role of post-translational modifications on protein-protein interactions with survivin

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Survivin as a prognostic/predictive marker and molecular target in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Monitoring survivin expression in cancer: implications for prognosis and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Prognostic Significance of Survivin Polymorphisms on Non-small Cell Lung Cancer Survival

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Clinico-pathologic relevance of Survivin splice variant expression in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Survivin is required for stable checkpoint activation in taxol-treated HeLa cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Association between class III β-tubulin expression and response to paclitaxel/vinorebine-based chemotherapy for non-small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Nuclear survivin as a biomarker for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Antisense inhibition of survivin expression as a cancer therapeutic

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Nanotechnology based platforms for survivin targeted drug discovery

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0079-4

21 January 2018

Inhibition of survivin expression and mechanisms of reversing drug-resistance of human lung adenocarcinoma cells by siRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survivin expression impacts prognostically on NSCLC but not SCLC

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of molecular pathology in non-small-cell lung carcinoma-now and in the future

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of the treatment of metastatic non small cell lung carcinoma: A practical approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving Outcomes in Advanced Lung Cancer: Maintenance therapy in non-small-cell lung carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survivin--prognostic tumor biomarker in human neoplasms--review

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reproducibility of subjective immunohistochemical estrogen- and progesterone receptor determination in human endometrium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24961465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-014-0079-4

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24961465%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853025&oldid=2177418117"